D, E., JP, T., G, B., AJH, B., T, T., & PJ, N. (2019). Cholinergic muscarinic M1 and M4 receptors as therapeutic targets for cognitive, behavioural, and psychological symptoms in psychiatric and neurological disorders. Drug discovery today, 24(12), 2307. https://doi.org/10.1016/j.drudis.2019.08.009
Chicago Style (17th ed.) CitationD, Erskine, Taylor JP, Bakker G, Brown AJH, Tasker T, and Nathan PJ. "Cholinergic Muscarinic M1 and M4 Receptors as Therapeutic Targets for Cognitive, Behavioural, and Psychological Symptoms in Psychiatric and Neurological Disorders." Drug Discovery Today 24, no. 12 (2019): 2307. https://doi.org/10.1016/j.drudis.2019.08.009.
MLA (9th ed.) CitationD, Erskine, et al. "Cholinergic Muscarinic M1 and M4 Receptors as Therapeutic Targets for Cognitive, Behavioural, and Psychological Symptoms in Psychiatric and Neurological Disorders." Drug Discovery Today, vol. 24, no. 12, 2019, p. 2307, https://doi.org/10.1016/j.drudis.2019.08.009.